Literature DB >> 3058019

Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme).

A Bianchi1, C Scieux, C M Salmeron, I Casin, Y Perol.   

Abstract

An enzyme immunoassay (EIA), Chlamydiazyme (Abbott Laboratories), was evaluated for its determination of MICs of 15 antimicrobial agents against Chlamydia trachomatis (MRC-1, LB, TRIC/GB/MRC-1 Gf [ATCC VR-1]). The inoculum size, incubation time, and enhancers were defined for the assessment of chlamydial antigen synthesis in HeLa 229 cells seeded as monolayers in 96-well plates. MICs were determined and defined as the lowest antibiotic concentrations required to inhibit, after 24 or 48 h of incubation, antigen production as determined by the EIA. The MICs (after 48 h) were similar to those determined by the peroxidase-antiperoxidase staining of inclusions. MIC determinations after 24 h were suitable for screening the activities of quinolones, but less so for measuring the susceptibility of C. trachomatis to macrolides and tetracyclines. MIC determination by EIA was rapid, appropriate for standardization, and less cumbersome than determination by quantification of inclusions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058019      PMCID: PMC175866          DOI: 10.1128/AAC.32.9.1350

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Antimicrobial chemotherapy of chlamydial infection: where next?

Authors:  G L Ridgway
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

2.  Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.

Authors:  R Cevenini; V Sambri; M La Placa
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

Review 3.  A review of the in-vitro activity of roxithromycin against genital pathogens.

Authors:  G L Ridgway
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

4.  A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.

Authors:  S J How; D Hobson; C A Hart; E Quayle
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

5.  Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.

Authors:  J M Bailey; C Heppleston; S J Richmond
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

6.  Relative resistance to erythromycin in Chlamydia trachomatis.

Authors:  A Mourad; R L Sweet; N Sugg; J Schachter
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.

Authors:  M R Hammerschlag
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

8.  The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.

Authors:  G L Ridgway; G Mumtaz; F G Gabriel; J D Oriel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

9.  In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  W R Bowie; C E Shaw; D G Chan; W A Black
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  Br J Vener Dis       Date:  1978-04
View more
  3 in total

1.  Expression and targeting of secreted proteins from Chlamydia trachomatis.

Authors:  Laura D Bauler; Ted Hackstadt
Journal:  J Bacteriol       Date:  2014-01-17       Impact factor: 3.490

2.  Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; B Jürgens-Saathoff; A P Hudson; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.